TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23277250

Group type: EXPERIMENTAL
Intervention: Iloperidone 8 mg BID
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Iloperidone 12 mg BID
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Iloperidone 24 mg QD
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Ziprasidone 80 mg BID
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Quetiapine 375 mg BID
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Iloperidone with metabolic inhibitors (paroxetine and ketoconazole)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Iloperidone
Number of subjects: 188
Study: 21199881

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with sulfadoxine‐pyrimethamine
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: Clinical malaria during pregnancy
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: Acute placental infection
Number of subjects: 1030
Study: 18164818

Group type: EXPERIMENTAL
Intervention: Alvimopan 0.5mg BID
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Alvimopan 1mg QD
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Alvimopan 1mg BID
Number of subjects: 522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study: 16437269

Group type: EXPERIMENTAL
Intervention: Open repair (OR) under local anesthesia
Number of subjects: 61

Group type: COMPARATOR
Intervention: Laparoscopic repair (LR) under general anesthesia
Number of subjects: 61
Study: 14609923

Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 419

Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 419
Study: 10934078

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin monotherapy with reevaluation at 3 days
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard therapy (choice and duration of antibiotics at the discretion of physicians)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin monotherapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 81
Study: 8681595

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1.5 mg/kg/hr iv) for 5 days in trauma patients (n = 15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1.5 mg/kg/hr iv) for 5 days in sepsis patients (n = 15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution as placebo in trauma patients (n = 15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution as placebo in sepsis patients (n = 15)
Number of subjects: 60
Study: 1558329

Group type: EXPERIMENTAL
Intervention: mPEG modified grass pollen mix allergen preparation (mPEG‐gm)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Partly purified grass pollen mix allergen preparation (gm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both treatments at high dose levels (120,000 BU)
Number of subjects: 30
Study: 6395323

Group type: EXPERIMENTAL
Intervention: tranexamic acid (Cyklocapron, 4.5 g per day for 6 weeks)
Number of subjects: 45
Study: 31433269

Group type: EXPERIMENTAL
Intervention: Fish oil (3000 mg/day, 1053 mg omega-3 fatty acids) plus wheat germ oil (300 mg/day, 0.765 mg vitamin E)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 46
Study: 31074700

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (5-7 days/week, energy expenditure 2,100-4,200 kcal/week for men and 1,600 kcal/week for women)
Number of subjects: 124
Study: 30672216

Group type: EXPERIMENTAL
Intervention: Three-promotion needling method (acupuncture with filiform needle, warm promotion with fire needle, and bleeding technique with three-edged needle)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Estazolam (1mg orally before sleep, once every 2 days for 4 weeks)
Number of subjects: 70
Study: 28065228

Group type: EXPERIMENTAL
Intervention: Ambu Aura-i
Number of subjects: 120

Group type: COMPARATOR
Intervention: Air-Q
Number of subjects: 120
Study: 24615079

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 20978932

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 360
Study: 20027432

Group type: EXPERIMENTAL
Intervention: ProTaper Universal rotary system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitiflex files
Number of subjects: 20
Study: 16697316

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study: 14759439

Group type: EXPERIMENTAL
Intervention: On-pump (CABG)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Off-pump (OPCAB)
Number of subjects: 160
Study: 11179277

Group type: EXPERIMENTAL
Intervention: Oral methionine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral homocysteine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (for methionine)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (for homocysteine)
Number of subjects: 22
Study: 9425678

Group type: EXPERIMENTAL
Intervention: Identifying target letters in multiletter strings with different interletter steps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identifying terminal letters first
Number of subjects: 0
Study: 8303206

Group type: EXPERIMENTAL
Intervention: Concentrated wheat fibre (11 grams of Fiberform)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 2963746

Group type: EXPERIMENTAL
Intervention: Low dose (300 mg/day) medroxyprogesterone acetate
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: High dose (1000 mg/day) medroxyprogesterone acetate
Number of subjects: 124
Study: 1267035

Group type: EXPERIMENTAL
Intervention: Active marijuana
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo marijuana
Number of subjects: 10
Study: 31427864

Group type: EXPERIMENTAL
Intervention: Living high-training low (LHTL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Living low-training low (LLTL)
Number of subjects: 24
Study: 28545189

Group type: EXPERIMENTAL
Intervention: Modified Triple Therapy (MTT): 20 mg omeprazole t.i.d., 500 mg amoxicillin t.i.d., and 500 mg clarithromycin b.i.d. for 14 days
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard Triple Therapy (STT): 20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., and 500 mg clarithromycin b.i.d. for 14 days
Number of subjects: 170
Study: 26179654

Group type: EXPERIMENTAL
Intervention: Human footprint (HFP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pteropus bat distribution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vegetation cover
Number of subjects: 0
Study: 23643313

Group type: EXPERIMENTAL
Intervention: Monaural galvanic vestibular stimulation (GVS) with 1 mA direct current for 3 seconds
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy control subjects (no stimulation)
Number of subjects: 32
Study: 20440106

Group type: EXPERIMENTAL
Intervention: Carbohydrate counting programme (CCP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no CCP)
Number of subjects: 56
Study: 19273701

Group type: EXPERIMENTAL
Intervention: Cetuximab and best supportive care (BSC)
Number of subjects: 572

Group type: COMPARATOR
Intervention: BSC alone
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Cetuximab in wild-type KRAS patients
Number of subjects: 572

Group type: COMPARATOR
Intervention: BSC alone in wild-type KRAS patients
Number of subjects: 572
Study: 17878149

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg yearly intravenous infusion)
Number of subjects: 2127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2127
Study: 14742396

Group type: EXPERIMENTAL
Intervention: Ballpen needle (B)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Sprotte needle (S)
Number of subjects: 700
Study: 11167370

Group type: COMPARATOR
Intervention: Freshly squeezed apple juice
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Freshly grated apple
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Freeze-dried apple powder
Number of subjects: 65
Study: 9129487

Group type: EXPERIMENTAL
Intervention: Psyllium (1.4 g/MJ)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Psyllium diet
Number of subjects: 59

Group type: COMPARATOR
Intervention: Wheat bran (control)
Number of subjects: 59
Study: 7708414

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine injected 35 min before incision
Number of subjects: 42

Group type: COMPARATOR
Intervention: Epidural normal saline injected 37 min before incision
Number of subjects: 42
Study: 2885462

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone for 7 days added to antibiotic regimen
Number of subjects: 10

Group type: COMPARATOR
Intervention: Antibiotic therapy alone
Number of subjects: 10
Study: 30246186

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with a temporary resin fixed partial denture
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventionally loaded implants with definitive multi-unit abutments
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (immediately loaded and conventionally loaded)
Number of subjects: 26
Study: 26949133

Group type: EXPERIMENTAL
Intervention: PACK‐CXL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (standard treatment alone)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 26201510

Group type: EXPERIMENTAL
Intervention: Weekly supervised group sessions of progressive balance training for two years, supplemented by individually prescribed home exercises
Number of subjects: 706

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Weekly supervised group sessions of progressive balance training for two years
Number of subjects: 706
Study: 23918953

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cancer recovery (MBCR)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy (SET)
Number of subjects: 271

Group type: COMPARATOR
Intervention: 1-day stress management control
Number of subjects: 271
Study: 21916739

Group type: EXPERIMENTAL
Intervention: Exposure to questions about life events (stressful events and sexual violation)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Exposure to questions about life events (other conditions)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control condition (no exposure to trauma-related questions)
Number of subjects: 219
Study: 18938022

Group type: EXPERIMENTAL
Intervention: Caries Check Blue (CCB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caries Check (CC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caries Detector (CD)
Number of subjects: 0
Study: 16675163

Group type: EXPERIMENTAL
Intervention: Outreach Case Management (OCM) for 6 weeks, designed to motivate and coach patients to re-enter treatment.
Number of subjects: 128

Group type: COMPARATOR
Intervention: Passive Referral (PR) for drug treatment, n=52.
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Outreach Case Management (OCM) for 6 weeks.
Number of subjects: 128
Study: 15579612

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 11760845

Group type: EXPERIMENTAL
Intervention: Children with high percent body fat
Number of subjects: 239

Group type: COMPARATOR
Intervention: Children born preterm
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Children with varying percent body fat
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Children with varying age
Number of subjects: 239
Study: 9304342

Group type: EXPERIMENTAL
Intervention: Bifidumbacterin forte
Number of subjects: 0
Study: 8292689

Group type: EXPERIMENTAL
Intervention: Bilateral ECT (BL)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Right Unilateral ECT (RUL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nasion-inion measurement
Number of subjects: 28
Study: 3729666

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride 0.1 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride 5 micrograms/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride 2.0 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31643142

Group type: EXPERIMENTAL
Intervention: Physical health nurse in the treating team (in addition to case manager and doctor) for a 12-week period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (case manager and doctor)
Number of subjects: 0
Study: 29105893

Group type: EXPERIMENTAL
Intervention: Conventional meal (potato-cheese cream followed by vanilla cream)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Unconventional meal (mixture of both creams)
Number of subjects: 22
Study: 26547590

Group type: EXPERIMENTAL
Intervention: Infant pulmonary function tests (iPFTs)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Mean baseline FEV0.5, FEF75 and FRC z-scores
Number of subjects: 73
Study: 24573661

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 3541

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed nuts
Number of subjects: 3541

Group type: COMPARATOR
Intervention: Control diet (advice on a low-fat diet)
Number of subjects: 3541
Study: 22412041

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 483

Group type: COMPARATOR
Intervention: Letrozole + Zoledronic acid
Number of subjects: 483
Study: 20798425

Group type: EXPERIMENTAL
Intervention: Myofeedback-based teletreatment for 4 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Myofeedback-based teletreatment
Number of subjects: 71
Study: 18072873

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 10 mg/d
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg/d
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 40 mg/d
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 1434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Bazedoxifene and Raloxifene
Number of subjects: 1434
Study: 16794892

Group type: EXPERIMENTAL
Intervention: Sevoflurane + > 65% N(2)O (Phase A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sevoflurane + > 65% N(2)O with reduced sevoflurane (Phase B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane (Control in Phase A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane (Control in Phase B)
Number of subjects: 80
Study: 12796576

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxandrolone twice a day (n = 14)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxandrolone
Number of subjects: 32
Study: 12634875

Group type: EXPERIMENTAL
Intervention: beta-blocker therapy (bisoprolol, carvedilol, metoprolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitor therapy
Number of subjects: 0
Study: 9033701

Group type: EXPERIMENTAL
Intervention: Manual inflating long balloon prototype cannula (group I)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Manual inflating short balloon cannula (group II)
Number of subjects: 52
Study: 1736733

Group type: EXPERIMENTAL
Intervention: 0.3 ppm NO2
Number of subjects: 40

Group type: COMPARATOR
Intervention: Purified air (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison of COPD and elderly normal subjects
Number of subjects: 40
Study: 6476789

Group type: EXPERIMENTAL
Intervention: 25 mg dose of pyridoxine hydrochloride
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 31246224

Group type: EXPERIMENTAL
Intervention: Default order option in the electronic medical record
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard practice (no default order)
Number of subjects: 0
Study: 30379814

Group type: EXPERIMENTAL
Intervention: Single dose of pentamidine isethionate (PI) 7 mg/kg
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Two doses of pentamidine isethionate (PI) 7 mg/kg
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Three doses of pentamidine isethionate (PI) 7 mg/kg
Number of subjects: 159
Study: 27075333

Group type: EXPERIMENTAL
Intervention: Patient-centered intervention consisting of a decision aid for knee OA and motivational interviewing
Number of subjects: 493

Group type: COMPARATOR
Intervention: Educational booklet about OA that did not mention joint replacement (Control)
Number of subjects: 493
Study: 25062131

Group type: EXPERIMENTAL
Intervention: Alcohol-assisted epithelial debridement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Mechanical epithelial debridement
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 23514685

Group type: EXPERIMENTAL
Intervention: Comfort control syringe (CCS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional injection technique
Number of subjects: 50
Study: 20654755

Group type: EXPERIMENTAL
Intervention: EE30/LNG150
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EE20/LNG100
Number of subjects: 97
Study: 17689509

Group type: EXPERIMENTAL
Intervention: Intracoronary BH4 (250 microg/min & 500 microg/min) co-administered with acetylcholine (Ach, 10(‐7) & 10(‐6) M)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Intracoronary BH4 (500 microg/min) co-administered with acetylcholine (Ach, 10(‐7) & 10(‐6) M)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no BH4 treatment)
Number of subjects: 57
Study: 16248952

Group type: EXPERIMENTAL
Intervention: Tumor vaccine (3 vaccinations at 2-week intervals, consisting of formalin-fixed HCC tissue fragments, biodegradable sustained-releasers of GM-CSF, IL-2, and an adjuvant)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (received only the adjuvant)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tumor vaccine
Number of subjects: 80
Study: 11895628

Group type: EXPERIMENTAL
Intervention: Ingestion of small amounts of allergenic foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold doses for allergenic foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concept of threshold level
Number of subjects: 0
Study: 10193870

Group type: EXPERIMENTAL
Intervention: New anthropometric prediction equation developed from stepwise regression analysis in the development group (n = 135) using weight, triceps skinfold, gender, ethnicity, and abdominal skinfold to estimate fat mass (FM) measured by DEXA.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (n = 67) used for cross-validation of the new prediction equation.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Previously published equations of Slaughter et al and Goran et al.
Number of subjects: 202
Study: 7766742

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.), Metronidazole (400 mg t.d.s.) for 14 days
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.), Metronidazole (400 mg t.d.s.) for 7 days
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg mane), Amoxycillin (500 mg t.d.s.) for 7 days and Metronidazole for 5 days
Number of subjects: 436

Group type: COMPARATOR
Intervention: 14 days treatment
Number of subjects: 436
Study: 2271374

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7411316

Group type: EXPERIMENTAL
Intervention: Special stimulation for babies to enhance interaction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Special training for mothers to enhance responsiveness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined stimulation for infants and training for mothers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular hospital care (control group)
Number of subjects: 0
Study: 31130153

Group type: EXPERIMENTAL
Intervention: Family history of alcohol problems (FHAP)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Family history of depression (FHD)
Number of subjects: 333
Study: 31494152

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) 2.5h after breakfast
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) 1h after breakfast
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Steady-State Exercise (SSE) 2.5h after breakfast
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) 1h and Steady-State Exercise (SSE) 1h
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) 1h and HIIE 2.5h
Number of subjects: 14
Study: 28968735

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study: 26899778

Group type: EXPERIMENTAL
Intervention: Lenalidomide (25 mg orally on days 1-21 every 28 days)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Investigator's choice monotherapy (rituximab, gemcitabine, fludarabine, chlorambucil, or cytarabine)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 254

Group type: COMPARATOR
Intervention: Investigator's choice
Number of subjects: 254
Study: 25493978

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1195
Study: 21818628

Group type: EXPERIMENTAL
Intervention: Galantamine treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy Control (HC)
Number of subjects: 28
Study: 19776140

Group type: EXPERIMENTAL
Intervention: 16 g prebiotics/d
Number of subjects: 10

Group type: COMPARATOR
Intervention: 16 g dextrin maltose/d
Number of subjects: 10
Study: 17309590

Group type: EXPERIMENTAL
Intervention: Full-mouth root planing (FMRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Quadrant wise scaling and root planing (QRP)
Number of subjects: 20